Latest Breaking News On - Mindleap health - Page 6 : comparemela.com

Mydecine Innovations Group, Inc., is pleased to announce that its subsidiary Mindleap Health a digital health platform and the world’s-first telemedicine application purpose-built for the psychedelic medicine industry, has filed a provisional patent for its technology platform in both The United States Patent and Trademark Office and the Canadian Intellectual Property Office. “As our company continues to innovate … Mydecine Innovations Group, Inc., ( CSE:MYCO ) ( OTC:MYCOF ) ( FSE:0NFA ) (“Mydecine” or the “Company”) is pleased to announce that its subsidiary Mindleap Health (“Mindleap”), a digital health platform and the world’s-first telemedicine application purpose-built for the psychedelic medicine industry, has filed a provisional patent for its technology platform in both The United States Patent and Trademark Office (USPTO) and the Canadian Intellectual Property Office.

United statesJack bunceJosh bartchCharles leeJoshua bartchAnne donohoe nick opichMindleap healthCorp communicationOur servicesMydecine innovations group media contactsMindleap health platform services disclaimerMindleap health incTrademark officeDigital mental healthCanadian securities exchangeCanadian intellectual property office